Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Harter, P; du Bois, A; Mahner, S; Pfisterer, J; Ortmann, O; Marth, C; Fink, D; Hilpert, F; Wagner, U; Sehouli, J (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe und Frauenheilkunde, 76(2):147-149.

Perren, T J; Swart, A M; Pfisterer, J; Ledermann, J A; Pujade-Lauraine, E; Kristensen, G; Carey, M S; Beale, P; Cervantes, A; Kurzeder, C; du Bois, A; Sehouli, J; Kimmig, R; Stähle, A; Collinson, F; Essapen, S; Gourley, C; Lortholary, A; Selle, F; Mirza, M R; Leminen, A; Plante, M; Stark, D; Qian, W; Parmar, M K B; Oza, A M (2011). A phase 3 trial of bevacizumab in ovarian cancer. New England Journal of Medicine, 365(26):2484-2496.

von Moos, R; Thuerlimann, B J K; Aapro, M; Rayson, D; Harrold, K; Sehouli, J; Scotte, F; Lorusso, D; Dummer, R; Lacouture, M E; Lademann, J; Hauschild, A (2008). Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts. European Journal of Cancer, 44(6):781-790.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

This list was generated on Fri Nov 24 23:33:16 2017 CET.